{
  "ptid_time": "116_S_4092_2011-09-21",
  "img_path": "/data/qiuhui/data/adni/images/116_S_4092/2011-09-21/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 42,644 mm³, 15.4% above the reference mean. With a Z-score of 0.41 (66.1th percentile), this represents normal volume ; hippocampal volume measures 6,832 mm³, 5.2% above the reference mean. With a Z-score of 0.42 (66.1th percentile), this represents normal volume ; whole brain volume measures 1,051,500 mm³, 13.3% above the reference mean. With a Z-score of 1.59 (94.5th percentile), this represents moderate enlargement; entorhinal cortex volume measures 3,361 mm³, 2.9% below the reference mean. With a Z-score of -0.16 (43.7th percentile), this represents normal volume ; fusiform gyrus volume measures 20,706 mm³, 28.5% above the reference mean. With a Z-score of 2.14 (98.4th percentile), this represents significant enlargement; middle temporal gyrus volume measures 19,216 mm³, 6.6% above the reference mean. With a Z-score of 0.59 (72.1th percentile), this represents normal volume . ",
  "text_data": "Age is 81.5 years. Gender is Female. Education: 14 years. Handedness: Right. Race: White. Medical history: Neurologic; Head, Eyes, Ears, Nose and Throat; Dermatologic-Connective Tissue; Musculoskeletal; Gastrointestinal; Allergies or Drug Sensitivities; Malignancy; Major Surgical Procedures. MMSE: 29.0. MoCA: 26.0. Logical Memory: 9.0. Laboratory findings: Monocytes: 0.63 (significant elevated); Monocytes: 12.00 (profound elevated); Basophils: 1.50 (significant elevated). APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.28 SUVR (moderate elevated); Amyloid beta: 1261.00 pg/mL (normal ); Total tau: 433.20 pg/mL (significant elevated); Phosphorylated tau: 41.02 pg/mL (significant elevated). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The brain volume measurements are largely within normal ranges or even enlarged, with no significant atrophy in key regions like the hippocampus or entorhinal cortex. However, the CSF biomarkers (elevated T-tau and P-tau with normal Aβ) suggest possible neurodegenerative changes, though cognitive scores (MMSE 29, MoCA 26) remain strong for age.  \n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (biomarker evidence of neurodegeneration without significant cognitive decline)  \n**Confidence:** **Medium** (biomarkers are concerning, but cognitive performance and brain volumes do not yet support dementia).  \n\n*Note: The elevated tau with normal Aβ is atypical for Alzheimer’s disease (usually both are abnormal), raising the possibility of non-AD tauopathy (e.g., primary age-related tauopathy [PART]). Further clinical correlation is needed.*",
  "timestamp": "2025-07-26T12:07:16.079991"
}